Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis in Which Methotrexate (MTX) Treatment is Not Effective
Phase of Trial: Phase I/II
Latest Information Update: 01 Mar 2017
Price : $35 *
At a glance
- Drugs Theralizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors TheraMAB
- 17 Feb 2017 Status changed from recruiting to completed.
- 17 Mar 2014 The first patient was treated at the end of December 2013 according to a TheraMAB media release. Trial pproval was granted by the Ministry of Health of the Russian Federation in October 2013.
- 17 Mar 2014 Planned number of patients changed from 18 to 120 based on information reported in a TheraMAB media release.